Abstract
The use of blood transfusions in medicine is so well established that the procedure is an afterthought to many physicians. Scientific advances have rendered blood and blood products extremely safe through the introduction of donor-deferral strategies, infectious-disease testing, pathogen-inactivation methods, and recombinant DNA technologies for particular therapeutic proteins. These advances have dramatically reduced the likelihood of transfusion-transmitted disease so that the risk of transfusion-associated human immunodeficiency virus 1 or hepatitis C infection, for example, is now on the order of 1 in 2 million donated units.1 Concern persists about the transmission of other infectious agents, for which testing is not . . .
Sign-in/Register to access full text options 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
